Intraday Price Movement and Market Context
The stock opened with a positive gap, registering an intraday high of Rs 257.85, a 2.5% gain from the prior close. However, this initial optimism quickly reversed as selling intensified, driving the price down to its intraday low of Rs 230.05. This represents a sharp decline of 8.55% from the previous session’s close, marking a notable intraday price pressure.
Gujarat Themis Biosyn Ltd’s performance today lagged behind the Pharmaceuticals & Biotechnology sector, underperforming by 7.16%. The broader market also faced headwinds, with the Sensex opening sharply lower by 1,018 points and closing down 542.01 points at 72,023.21, a 2.12% drop. The Sensex is currently trading close to its 52-week low, just 0.83% above the level of 71,425.01, and remains below its 50-day moving average, signalling a bearish trend.
The stock’s decline today adds to a recent negative trend, with Gujarat Themis Biosyn Ltd falling for two consecutive days, accumulating a 14.37% loss over this period. This short-term weakness is compounded by the stock trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — indicating sustained downward momentum.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Performance Relative to Benchmarks
Over various time frames, Gujarat Themis Biosyn Ltd has underperformed the Sensex significantly. The stock’s one-day return of -8.55% contrasts with the Sensex’s -2.10%. Over one week, the stock declined by 11.11%, while the Sensex fell by 0.90%. The one-month performance shows a 22.14% drop for the stock against a 10.22% fall in the Sensex. The disparity widens over three months, with Gujarat Themis Biosyn Ltd down 47.13% compared to the Sensex’s 14.92% decline.
Year-to-date figures reveal a 48.01% loss for the stock, substantially worse than the Sensex’s 15.47% decrease. Even on a one-year basis, the stock’s decline of 18.28% exceeds the Sensex’s 6.94% fall. Despite these recent setbacks, the company’s longer-term returns remain robust, with three-year gains of 152.20%, five-year returns of 756.84%, and an impressive ten-year appreciation of 3,368.26%, all well above the Sensex’s respective returns.
Technical Indicators and Market Sentiment
Technical analysis points to a predominantly bearish outlook for Gujarat Themis Biosyn Ltd. The daily moving averages are all trending lower, reinforcing the downward price pressure. Weekly and monthly MACD indicators are bearish or mildly bearish, while Bollinger Bands on both weekly and monthly charts also signal bearish momentum. The KST indicator aligns with this view, showing bearish tendencies on a weekly basis and mild bearishness monthly.
Other technical signals present a mixed picture: the weekly On-Balance Volume (OBV) is mildly bearish, whereas the monthly OBV is bullish, suggesting some accumulation at longer time frames despite short-term selling. The Dow Theory assessments indicate mild bearishness on both weekly and monthly scales, consistent with the overall cautious market sentiment.
The company’s Mojo Score currently stands at 37.0, with a Mojo Grade of Sell, downgraded from Hold on 21 Jan 2026. This downgrade reflects the deteriorating technical and fundamental outlook. Gujarat Themis Biosyn Ltd is classified as a small-cap stock within the Pharmaceuticals & Biotechnology sector, which has faced sector-wide pressures in recent sessions.
Holding Gujarat Themis Biosyn Ltd from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Broader Market Environment
The decline in Gujarat Themis Biosyn Ltd’s share price coincides with a challenging market backdrop. The Sensex’s sharp gap down opening and subsequent fall of over 2% reflect widespread risk aversion. The index’s position below key moving averages and proximity to its 52-week low underscore the prevailing bearish sentiment.
Sectoral pressures in Pharmaceuticals & Biotechnology have contributed to the stock’s underperformance. The sector’s relative weakness today, with Gujarat Themis Biosyn Ltd lagging by over 7%, highlights the stock-specific and sector-wide challenges faced by investors.
Despite the negative intraday price action, the stock remains only 3.63% above its 52-week low of Rs 221.7, indicating that it is trading near historically low levels. This proximity to the lower price band adds to the cautious tone surrounding the stock’s immediate outlook.
Summary of Price and Technical Metrics
To summarise, Gujarat Themis Biosyn Ltd’s intraday low of Rs 230.05 represents a significant 8.55% decline on 30 Mar 2026. The stock’s failure to sustain early gains and subsequent fall below all major moving averages signals persistent selling pressure. Technical indicators predominantly suggest bearish momentum, while the stock’s downgrade to a Sell grade by MarketsMOJO reflects the current negative sentiment.
The broader market’s weakness and sectoral headwinds have compounded the stock’s decline, with the Sensex also trading near its 52-week low. The stock’s recent performance over multiple time frames continues to trail the benchmark index, underscoring the challenges faced in the near term.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
